Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
- 23 November 2011
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 18 (11), 1390-1400
- https://doi.org/10.1016/j.chembiol.2011.08.014
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair networkThe Journal of cell biology, 2010
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14Nature, 2010
- Differential Roles for DNA Polymerases Eta, Zeta, and REV1 in Lesion Bypass of Intrastrand versus Interstrand DNA Cross-LinksMolecular and Cellular Biology, 2010
- Principles of ubiquitin and SUMO modifications in DNA repairNature, 2009
- Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia PhenotypeDevelopmental Cell, 2009
- Preclinical Evaluation of Gemcitabine Combination Regimens for Application in Acute Myeloid LeukemiaClinical Cancer Research, 2005
- Mechanism and function of deubiquitinating enzymesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004
- Interaction of Human DNA Polymerase η with Monoubiquitinated PCNAMolecular Cell, 2004
- Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol DesignJNCI Journal of the National Cancer Institute, 1994
- The role of pimozide in clinical psychiatry: a review.1991